Patents by Inventor Andrew Pincetic

Andrew Pincetic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-SIRPa antibodies and methods of use thereof
    Patent number: 11976119
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Grant
    Filed: March 29, 2022
    Date of Patent: May 7, 2024
    Inventors: Andrew Pincetic, Wei-Hsien Ho, Patricia Culp, Arnon Rosenthal
  • Anti-SIRP-Alpha Antibodies and Methods of Use Thereof
    Publication number: 20240082395
    Abstract: The invention provides anti-SIRPA antibodies, methods of generating such antibodies, and therapeutic uses and methods employing the antibodies.
    Type: Application
    Filed: August 23, 2023
    Publication date: March 14, 2024
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Arnon Rosenthal, Seung-Joo Lee
  • Anti-SIRP-alpha antibodies and methods of use thereof
    Patent number: 11779642
    Abstract: The invention provides anti-SIRPA antibodies, methods of generating such antibodies, and therapeutic uses and methods employing the antibodies.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: October 10, 2023
    Assignee: Alector LLC
    Inventors: Andrew Pincetic, Arnon Rosenthal, Seung-Joo Lee
  • Anti-Inflammatory Polypeptides
    Publication number: 20230295306
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Application
    Filed: February 22, 2023
    Publication date: September 21, 2023
    Applicant: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-TREM1 Antibodies and Methods of Use Thereof
    Publication number: 20230121869
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: September 13, 2022
    Publication date: April 20, 2023
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Arnon Rosenthal, Helen Lam, Francesca Avogadri-Connors, Seung-Joo Lee
  • Anti-inflammatory polypeptides
    Patent number: 11613579
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: March 28, 2023
    Assignee: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-inflammatory polypeptides
    Patent number: 11608379
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: March 21, 2023
    Assignee: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-TREM1 antibodies and methods of use thereof
    Patent number: 11472877
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: October 18, 2022
    Assignee: Alector LLC
    Inventors: Andrew Pincetic, Arnon Rosenthal, Helen Lam, Francesca Avogadri-Connors, Seung-Joo Lee
  • Anti-SIRPa Antibodies and Methods of Use Thereof
    Publication number: 20220289844
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: March 29, 2022
    Publication date: September 15, 2022
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Wei-Hsien Ho, Patricia Culp, Arnon Rosenthal
  • Anti-SIRPA antibodies and methods of use thereof
    Patent number: 11319373
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: May 3, 2022
    Assignee: Alector LLC
    Inventors: Andrew Pincetic, Wei-Hsien Ho, Patricia Culp, Arnon Rosenthal
  • Anti-SIRP-Beta1 Antibodies and Methods of Use Thereof
    Publication number: 20210277113
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRP?1 polypeptide, e.g., a human SIRP?1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: June 28, 2019
    Publication date: September 9, 2021
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Patricia Culp, Arnon Rosenthal
  • ANTI-INFLAMMATORY POLYPEPTIDES
    Publication number: 20210130472
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 6, 2021
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • ANTI-INFLAMMATORY POLYPEPTIDES
    Publication number: 20210101986
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Application
    Filed: November 25, 2020
    Publication date: April 8, 2021
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-inflammatory polypeptides
    Patent number: 10894832
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: January 19, 2021
    Assignee: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-inflammatory polypeptides
    Patent number: 10851167
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 1, 2020
    Assignee: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-inflammatory polypeptides
    Patent number: 10844125
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: November 24, 2020
    Assignee: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic
  • Anti-TREM1 Antibodies and Methods of Use Thereof
    Publication number: 20200131264
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: March 3, 2017
    Publication date: April 30, 2020
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Arnon Rosenthal, Helen Lam, Francesca Avogadri-Connors, Seung-Joo Lee
  • Anti-Sirpa Antibodies and Methods of Use Thereof
    Publication number: 20190359707
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Wei-Hsien Ho, Patricia Culp, Arnon Rosenthal
  • Anti-SIRP-Alpha Antibodies and Methods of Use Thereof
    Publication number: 20190275150
    Abstract: The invention provides anti-SIRPA antibodies, methods of generating such antibodies, and therapeutic uses and methods employing the antibodies.
    Type: Application
    Filed: December 8, 2017
    Publication date: September 12, 2019
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Arnon Rosenthal, Seung-Joo Lee
  • Anti-Inflammatory Polypeptides
    Publication number: 20180179284
    Abstract: This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders.
    Type: Application
    Filed: December 18, 2017
    Publication date: June 28, 2018
    Applicant: The Rockefeller University
    Inventors: Jeffrey V. Ravetch, Andrew Pincetic